Assetmark »

Silence Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2026-09-30 $1.3k 118 10.93

More positions owned by Assetmark

Vanguard World Mrngstr Mega Cap (MGK)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard World Mrngstr Val Etf (MGV)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Vanguard Index Fds MRNGSTR SML CP V (VBR)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Mrngstr Md Cp Va (VOE)
Ishares Core Msci Emkt (IEMG)
Spdr Series Trust ST STR PR SP1500 (SPTM)
Meta Platforms Cl A (META)
Vanguard Index Fds MRNGSTR MD CP GR (VOT)

View all positions for Assetmark

Top funds holding Silence Therapeutics

Siren
TCG Crossover Management
Redmile Group
Nantahala Capital Management
Citadel Advisors
Polygon Management
Nextech Invest
Millennium Management
Ikarian Capital
Soleus Capital Management
Balyasny Asset Management
5AM Venture Management
Caption Management
Dr. Jeffrey R. Jay, M.D.
Jane Street

View all funds holding Silence Therapeutics